The Influenza Virus Toolkit: a reagent sharing resource for influenza research
- Funded by UK Research and Innovation (UKRI)
- Total publications:2 publications
Grant number: MC_PC_21023
Grant search
Key facts
Disease
UnspecifiedStart & end year
20222023Known Financial Commitments (USD)
$269,950.05Funder
UK Research and Innovation (UKRI)Principal Investigator
Dr. Edward HutchinsonResearch Location
United KingdomLead Research Institution
University of GlasgowResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The aim of this proposal is to develop an influenza virus reagent resource, an outward-facing national asset for the long-term storage and redistribution of influenza virology reagents. Influenza viruses are one of the leading global causes of respiratory illness and have been the subject of intensive research over decades. This has created a highly active but dispersed research environment. A wealth of non-commercial reagents exists, but they are challenging to identify and time-consuming to obtain, and requests for them create significant administrative and archiving burdens for the originating groups. We will address this by creating the Influenza Virus Toolkit, a resource-sharing initiative modelled after our recently developed Coronavirus Toolkit. This will build on the established MRC Reagents and Services framework and the CVR Reagent Repository to provide a sustainable, long-term framework for the archiving and redistribution of reagents for influenza virus research, for academics and industry, in the UK and overseas. This project will mobilise resources in the extremely active field of influenza virology, in particular catalysing resource sharing from the current MRC portfolio of virology research. It will foster open-science and a culture of collaboration among influenza researchers. Importantly, it will also create a key resource for the rapid provision of research reagents during the next influenza pandemic.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC